Hormel Foods to Acquire Brakebush for $1.055B, Expanding Value-Added Chicken Platform
HRL is trading near its 52-week low of $19.42 (3.2% above the low).
Summary
Hormel Foods agreed to acquire Brakebush Brothers, a leading value-added chicken company, for $1.055 billion in cash. The deal expands Hormel's Foodservice platform and is expected to close in Q1 fiscal 2027, subject to regulatory approval.
Key Events · M&A and Partnerships · HRL
-
Definitive Agreement Signed
Hormel Foods entered into a Membership Interest Purchase Agreement on September 29, 2026 to acquire all outstanding membership interests of Brakebush Brothers, LLC for a base purchase price of $1.055 billion in cash, subject to customary adjustments.
-
Strategic Expansion into Value-Added Chicken
Brakebush generated approximately $1.2 billion in net sales over the last 12 months, with ~90% of revenue from foodservice. The acquisition significantly expands Hormel's position in value-added chicken and strengthens its Foodservice platform.
-
Valuation and Synergies
The transaction implies an adjusted EBITDA multiple of 10.7x, or 8.9x after expected run-rate cost synergies of ~$20 million by end of fiscal 2028. Management expects the deal to be accretive to adjusted EPS beginning fiscal 2028.
-
Financing and Leverage
The acquisition will be financed with a combination of cash on hand and long-term debt. Post-acquisition net debt to adjusted EBITDA is expected to be in the low-2x range, with management committed to maintaining an investment-grade rating.
Analysis · HRL · Manufacturing
Hormel Foods is making its largest acquisition in years, paying $1.055 billion in cash for Brakebush Brothers, a leading value-added chicken company with approximately $1.2 billion in annual net sales. The deal significantly expands Hormel's Foodservice segment and positions it in one of the fastest-growing protein categories. At 10.7x adjusted EBITDA (8.9x after synergies), the valuation is substantial but reflects Brakebush's scale and growth profile. The acquisition will be financed with cash and new debt, pushing net debt to adjusted EBITDA toward the low-2x range — still within investment-grade territory but a meaningful step up from the current 1.5x. Management expects the deal to be accretive to adjusted EPS beginning fiscal 2028, with ~$20 million in run-rate cost synergies by end of fiscal 2028. The transaction is subject to HSR antitrust review and customary closing conditions, with a target close in Q1 fiscal 2027.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 36.8% of the 990 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.55%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HRL was trading at $20.05 on NYSE in the Manufacturing sector, with a market capitalization of approximately $10.9B. The 52-week trading range was $19.42 to $26.60. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.